September 18, 2020
Pharmacy Update

Disclaimer: We are getting frequent COVID-related questions about drug concerns and potential interactions. This information is as of September 16, 2020. We will do our best to keep you up to date with this ever evolving situation. This is the most update information at the time of publication.

Note: There are no Food and Drug Administration (FDA) approved therapies for treatment or prevention of COVID-19. If at all possible, it is best to have patients enrolled in a clinical trial.
In this issue:

PRELIMINARY FINDINGS ANNOUNCEMENT FOR BARICITINIB COMBINATION WITH REMDESIVIR

ASTRAZENECA VACCINE PHASE 3 TRIAL TO RESUME IN THE UNITED KINGDOM

GENERAL PHARMACY:
  • Selected CDC Influenza Vaccine Recommendations for Special Populations 2020-2021
  • New Asthma Indication for Trelegy Epplipta
SWHR COVID-19 News recent Issues:
Contact Us
If you have questions about items in the SWHR COVID-19 News or Southwestern Health Resources, send us an email: [email protected] →